FDA Recall of Tandem Insulin Pumps Due to User Guide Errors
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Tandem Diabetes Care is recalling 1,380 insulin pumps because of translation errors in the Czech language user guide, which could lead to unintended insulin delivery and potential health risks.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on April 8, 2026 and geographically references Czech Republic and Slovakia. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, cpsc, Devices.
What Happened
Tandem Diabetes Care, Inc. has initiated a voluntary recall due to multiple translation errors in the Czech language user guide for their insulin pumps. The most significant error incorrectly instructs users to verify that the infusion set is connected to the body, instead of confirming it is not connected, which could result in unintended insulin delivery and potentially lead to a hypoglycemic event.
Which Products Are Affected
The affected products are Tandem pumps, which are battery-operated infusion pumps for basal and bolus delivery of insulin. Specifically, this involves 1,380 units with Version 7.8.1 and UDI: (01)008500066132625. The recall applies to products distributed internationally in the countries of Czech Republic and Slovakia.
What You Should Do
Consumers who have received the affected Czech language user guide should contact Tandem Diabetes Care, Inc. for further instructions, as the recall was initiated via letter. For returns or refunds, reach out to the firm at their address: 12400 High Bluff Dr, San Diego, CA 92130-3077, using the recall number Z-1636-2026.
Why This Matters
This recall addresses a potential health risk from incorrect user instructions, which could lead to unintended insulin delivery and hypoglycemia, affecting user safety in the specified regions.
Source
Attribution: FDA Recall Notice, event ID 98478, reported on 20260401.
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (1,410 characters here).
Similar severity timing
Same severity (medium) notices issued closest in time to April 8, 2026.
Frequently Asked Questions
Common questions about this FDA recall.